Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis?

Author(s): Tahir Sulehria, Adrian M. Corbett*, Neelima Sharma, Devipriyanka Nagarajan, Amani Abushamma, Samantha Gagle, Alee Johnson

Journal Name: Recent Patents on Drug Delivery & Formulation
Continued as Recent Advances in Drug Delivery and Formulation

Volume 14 , Issue 3 , 2020


Graphical Abstract:


Abstract:

Introduction: The purpose of this study was to determine if pharmacological treatment could increase progenitor cell proliferation in the Sub-ventricular Zone of aged rats. Previous work had shown that increasing progenitor cell proliferation in this region correlated well (R2=0.78; p= 0.0007) with functional recovery in a damaged corpus callosum (white matter tract), suggesting that progenitor cell proliferation results in oligodendrocytes in this region.

Methods: 10 month old male and female Sprague Dawley rats were fed the drugs for 30 days in cookie dough, then immunocytochemistry was performed on coronal brain sections, using Ki67 labeling to determine progenitor cell proliferation.

Results: Female rats showed low endogenous (control) progenitor cell proliferation, significantly different from male rats (P<0.0001), at this age. Ascorbic Acid (20 mg/kg, daily for 30 days) increased progenitor cell proliferation overall, but maintained the innate gender difference in stem cell proliferation (P=0.001). Prozac (5 mg/kg, daily for 30 days) increased progenitor cell proliferation for females but decreased stem cell proliferation for males, again showing a gender difference (P<0.0001). Simvastatin (1 mg/kg for 30 days) also increased progenitor cell proliferation in females and decreased progenitor cell proliferation in males, leading to a significant gender difference.

Discussion: The three drug combinations (fluoxetine, simvastatin, and ascorbic acid, patent # 9,254,281) led to ~ 4 fold increase in progenitor cell proliferation in females, while male progenitor cell proliferation was highest with 50 mg/kg ascorbic acid. However, the ascorbic acid increase in proliferation appears to be only on the sides of the ventricles, which is not the region that normally gives rise to oligodendrocytes.

Conclusion: There are innate gender differences in progenitor cell proliferation at the Sub-Ventricular Zone at middle age in rats, possibly due to the loss of estrogen in females. We also see notable gender differences in progenitor cell proliferation in the Sub ventricular Zone in response to common drugs, such as fluoxetine, simvastatin and Vitamin C (ascorbic acid).

Keywords: Fluoxetine, simvastatin, ascorbic acid, sub ventricular zone, progenitor cell, stem cell, Ki67.

[1]
van Strien ME, Sluijs JA, Reynolds BA, Steindler DA, Aronica E, Hol EM. Isolation of neural progenitor cells from the human adult subventricular zone based on expression of the cell surface marker CD271. Stem Cells Transl Med 2014; 3(4): 470-80.
[http://dx.doi.org/10.5966/sctm.2013-0038] [PMID: 24604282]
[2]
Nagarajan D. Correlating innate functional recovery from stroke either with stem cell proliferation and/or limb rehabilitation. Wright State University: Wright State University 2016.
[3]
Xing YL, Röth PT, Stratton JA, et al. Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination. J Neurosci 2014; 34(42): 14128-46.
[http://dx.doi.org/10.1523/JNEUROSCI.3491-13.2014] [PMID: 25319708]
[4]
Butovsky O, Landa G, Kunis G, et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 2006; 116(4): 905-15.
[http://dx.doi.org/10.1172/JCI26836] [PMID: 16557302]
[5]
Suri D, Veenit V, Sarkar A, et al. Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition. Biol Psychiatry 2013; 73(7): 658-66.
[http://dx.doi.org/10.1016/j.biopsych.2012.10.023] [PMID: 23237316]
[6]
Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 1996; 16(6): 2027-33.
[http://dx.doi.org/10.1523/JNEUROSCI.16-06-02027.1996] [PMID: 8604047]
[7]
Shetty AK, Hattiangady B, Shetty GA. Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: Role of astrocytes. Glia 2005; 51(3): 173-86.
[http://dx.doi.org/10.1002/glia.20187] [PMID: 15800930]
[8]
Lim DA, Alvarez-Buylla A. The adult ventricular-subventricular zone (v-svz) and olfactory bulb (ob) neurogenesis. Cold Spring Harb Perspect Biol 2016; 8(5)a018820
[http://dx.doi.org/10.1101/cshperspect.a018820] [PMID: 27048191]
[9]
Wang X, Dong C, Sun L, et al. Quantitative proteomic analysis of age-related subventricular zone proteins associated with neurodegenerative disease. Sci Rep 2016; 6: 37443.
[http://dx.doi.org/10.1038/srep37443] [PMID: 27857231]
[10]
Mirescu C, Gould E. Stress and adult neurogenesis. Hippocampus 2006; 16(3): 233-8.
[http://dx.doi.org/10.1002/hipo.20155] [PMID: 16411244]
[11]
Mirescu C, Peters JD, Gould E. Early life experience alters response of adult neurogenesis to stress. Nat Neurosci 2004; 7(8): 841-6.
[http://dx.doi.org/10.1038/nn1290] [PMID: 15273691]
[12]
Coe CL, Kramer M, Czéh B, et al. Prenatal stress diminishes neurogenesis in the dentate gyrus of juvenile rhesus monkeys. Biol Psychiatry 2003; 54(10): 1025-34.
[http://dx.doi.org/10.1016/S0006-3223(03)00698-X] [PMID: 14625144]
[13]
Gould E, Tanapat P, McEwen BS, Flügge G, Fuchs E. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 1998; 95(6): 3168-71.
[http://dx.doi.org/10.1073/pnas.95.6.3168] [PMID: 9501234]
[14]
Mori K, Kaneko YS, Nakashima A, et al. Subventricular zone under the neuroinflammatory stress and Parkinson’s disease. Cell Mol Neurobiol 2012; 32(5): 777-85.
[http://dx.doi.org/10.1007/s10571-011-9783-1] [PMID: 22189676]
[15]
Czéh B, Müller-Keuker JI, Rygula R, et al. Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology 2007; 32(7): 1490-503.
[http://dx.doi.org/10.1038/sj.npp.1301275] [PMID: 17164819]
[16]
Veena J, Rao BS, Srikumar BN. Regulation of adult neurogenesis in the hippocampus by stress, acetylcholine and dopamine. J Nat Sci Biol Med 2011; 2(1): 26-37.
[http://dx.doi.org/10.4103/0976-9668.82312] [PMID: 22470231]
[17]
Dong Y, Jiang A, Yang H, Chen H, Wang Y. Phytoestrogen α-zearalanol improves memory impairment and hippocampal neurogenesis in ovariectomized mice. ScientificWorldJournal 2014; 2014862019
[http://dx.doi.org/10.1155/2014/862019] [PMID: 25143992]
[18]
Franklin TB, Perrot-Sinal TS. Sex and ovarian steroids modulate Brain-Derived Neurotrophic Factor (BDNF) protein levels in rat hippocampus under stressful and non-stressful conditions. Psychoneuroendocrinol 2006; 31(1): 38-48.
[http://dx.doi.org/10.1016/j.psyneuen.2005.05.008] [PMID: 15996825]
[19]
Chiba S, Suzuki M, Yamanouchi K, Nishihara M. Involvement of granulin in estrogen-induced neurogenesis in the adult rat hippocampus. J Reprod Dev 2007; 53(2): 297-307.
[http://dx.doi.org/10.1262/jrd.18108] [PMID: 17179653]
[20]
Torner L, Karg S, Blume A, et al. Prolactin prevents chronic stress-induced decrease of adult hippocampal neurogenesis and promotes neuronal fate. J Neurosci 2009; 29(6): 1826-33.
[http://dx.doi.org/10.1523/JNEUROSCI.3178-08.2009] [PMID: 19211889]
[21]
Bridges RS, Grattan DR. Prolactin-induced neurogenesis in the maternal brain. Trends Endocrinol Metab 2003; 14(5): 199-201.
[http://dx.doi.org/10.1016/S1043-2760(03)00082-1] [PMID: 12826322]
[22]
Larsen CM, Grattan DR. Prolactin-Induced mitogenesis in the subventricular zone of the maternal brain during early pregnancy is essential for normal postpartum behavioral responses in the mother. Endocrinol 2010; 151(8): 3805-14.
[http://dx.doi.org/10.1210/en.2009-1385] [PMID: 20484459]
[23]
Chen Z, Ye R, Goldman SA. Testosterone modulation of angiogenesis and neurogenesis in the adult songbird brain. Neuroscience 2013; 239: 139-48.
[http://dx.doi.org/10.1016/j.neuroscience.2012.12.043] [PMID: 23291451]
[24]
Allen KM, Purves-Tyson TD, Fung SJ, Shannon Weickert C. The effect of adolescent testosterone on hippocampal BDNF and TrkB mRNA expression: relationship with cell proliferation. BMC Neurosci 2015; 16: 4.
[http://dx.doi.org/10.1186/s12868-015-0142-x] [PMID: 25886766]
[25]
Lee E, Son H. Adult hippocampal neurogenesis and related neurotrophic factors. BMB Rep 2009; 42(5): 239-44.
[http://dx.doi.org/10.5483/BMBRep.2009.42.5.239] [PMID: 19470236]
[26]
Larsen MH, Rosenbrock H, Sams-Dodd F, Mikkelsen JD. Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine. Eur J Pharmacol 2007; 555(2-3): 115-21.
[http://dx.doi.org/10.1016/j.ejphar.2006.10.029] [PMID: 17112503]
[27]
Wu H, Lu D, Jiang H, et al. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 2008; 25(2): 130-9.
[http://dx.doi.org/10.1089/neu.2007.0369] [PMID: 18260796]
[28]
Corbett AM, Sieber S, Wyatt N, et al. Increasing neurogenesis with fluoxetine, simvastatin and ascorbic Acid leads to functional recovery in ischemic stroke. Recent Pat Drug Deliv Formul 2015; 9(2): 158-66.
[http://dx.doi.org/10.2174/1872211309666150122102846] [PMID: 25612744]
[29]
Corbett A, McGowin A, Sieber S, Flannery T, Sibbitt B. A method for reliable voluntary oral administration of a fixed dosage (mg/kg) of chronic daily medication to rats. Lab Anim 2012; 46(4): 318-24.
[http://dx.doi.org/10.1258/la.2012.012018] [PMID: 22969146]
[30]
Cowen DS, Takase LF, Fornal CA, Jacobs BL. Age-dependent decline in hippocampal neurogenesis is not altered by chronic treatment with fluoxetine. Brain Res 2008; 1228: 14-9.
[http://dx.doi.org/10.1016/j.brainres.2008.06.059] [PMID: 18616933]
[31]
De Nicola AF, Pietranera L, Beauquis J, Ferrini MG, Saravia FE. Steroid protection in aging and age-associated diseases. Exp Gerontol 2009; 44(1-2): 34-40.
[http://dx.doi.org/10.1016/j.exger.2008.03.005] [PMID: 18445514]
[32]
Lee J, Duan W, Mattson MP. Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 2002; 82(6): 1367-75.
[http://dx.doi.org/10.1046/j.1471-4159.2002.01085.x] [PMID: 12354284]
[33]
Mudò G, Bonomo A, Di Liberto V, Frinchi M, Fuxe K, Belluardo N. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm (Vienna) 2009; 116(8): 995-1005.
[http://dx.doi.org/10.1007/s00702-009-0207-z] [PMID: 19291360]
[34]
Kang SS, Keasey MP, Arnold SA, Reid R, Geralds J, Hagg T. Endogenous CNTF mediates stroke-induced adult CNS neurogenesis in mice. Neurobiol Dis 2013; 49: 68-78.
[http://dx.doi.org/10.1016/j.nbd.2012.08.020] [PMID: 22960105]
[35]
Kelleher-Andersson J. Neurogenesis as a potential therapeutic strategy for neurodegenerative disorders. J Alzheimers Dis 2004; 6(6): 19-25.
[PMID: 15665409]
[36]
Bolognin S, Buffelli M, Puoliväli J, Iqbal K. Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Neurobiol Aging 2014; 35(9): 2134-46.
[http://dx.doi.org/10.1016/j.neurobiolaging.2014.02.017] [PMID: 24702821]
[37]
Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22(3): 659-61.
[http://dx.doi.org/10.1096/fj.07-9574LSF] [PMID: 17942826]
[38]
Guirado R, Sanchez-Matarredona D, Varea E, Crespo C, Blasco-Ibáñez JM, Nacher J. Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. BMC Neurosci 2012; 13: 5.
[http://dx.doi.org/10.1186/1471-2202-13-5] [PMID: 22221403]
[39]
Ohira K, Miyakawa T. Chronic treatment with fluoxetine for more than 6 weeks decreases neurogenesis in the subventricular zone of adult mice. Mol Brain 2011; 4: 10.
[http://dx.doi.org/10.1186/1756-6606-4-10] [PMID: 21385396]
[40]
Wang N, Lu Y, Wang K, et al. Simvastatin attenuates neurogenetic damage and improves neurocongnitive deficits induced by isoflurane in neonatal rats Cell physio biochem 2018; 46(2): 618-32.
[http://dx.doi.org/10.1159/000488630]
[41]
Carson RA, Rudine AC, Tally SJ, et al. Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms. PLoS One 2018; 13(5)e0196387
[http://dx.doi.org/10.1371/journal.pone.0196387] [PMID: 29738536]
[42]
Miron VE, Zehntner SP, Kuhlmann T, et al. Statin therapy inhibits remyelination in the central nervous system. Am J Pathol 2009; 174(5): 1880-90.
[http://dx.doi.org/10.2353/ajpath.2009.080947] [PMID: 19349355]
[43]
Bond AM, Ming GL, Song H. Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell 2015; 17(4): 385-95.
[http://dx.doi.org/10.1016/j.stem.2015.09.003] [PMID: 26431181]
[44]
May JM. Vitamin C transport and its role in the central nervous system. Subcell Biochem 2012; 56: 85-103.
[http://dx.doi.org/10.1007/978-94-007-2199-9_6] [PMID: 22116696]
[45]
May JM. The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C. Br J Pharmacol 2011; 164(7): 1793-801.
[http://dx.doi.org/10.1111/j.1476-5381.2011.01350.x] [PMID: 21418192]
[46]
Sutachan JJ, Casas Z, Albarracin SL, et al. Cellular and molecular mechanisms of antioxidants in Parkinson’s disease. Nutr Neurosci 2012; 15(3): 120-6.
[http://dx.doi.org/10.1179/1476830511Y.0000000033] [PMID: 22732354]
[47]
Bowman GL. Ascorbic acid, cognitive function, and Alzheimer’s disease: A current review and future direction. Biofactors 2012; 38(2): 114-22.
[http://dx.doi.org/10.1002/biof.1002] [PMID: 22419527]
[48]
Covarrubias-Pinto A, Acuña AI, Beltrán FA, Torres-Díaz L, Castro MA. Old things new view: Ascorbic acid protects the brain in neurodegenerative disorders. Int J Mol Sci 2015; 16(12): 28194-217.
[http://dx.doi.org/10.3390/ijms161226095] [PMID: 26633354]
[49]
Newville J, Jantzie LL, Cunningham LA. Embracing oligodendrocyte diversity in the context of perinatal injury. Neural Regen Res 2017; 12(10): 1575-85.
[http://dx.doi.org/10.4103/1673-5374.217320] [PMID: 29171412]
[50]
Tsai SJ. Statins may enhance the proteolytic cleavage of proBDNF: Implications for the treatment of depression. Med Hypotheses 2007; 68(6): 1296-9.
[http://dx.doi.org/10.1016/j.mehy.2006.09.043] [PMID: 17097821]
[51]
Tsai SJ. Statins may act through increasing tissue plasminogen activator/plasmin activity to lower risk of Alzheimer’s disease. CNS Spectr 2009; 14(5): 234-5.
[http://dx.doi.org/10.1017/S1092852900025360] [PMID: 19407721]
[52]
Su F, Yi H, Xu L, Zhang Z. Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro. Neuroscience 2015; 294: 60-8.
[http://dx.doi.org/10.1016/j.neuroscience.2015.02.028] [PMID: 25711936]
[53]
Fenn AM, Henry CJ, Huang Y, Dugan A, Godbout JP. Lipopolysaccharide-induced interleukin (IL)-4 receptor-α expression and corresponding sensitivity to the M2 promoting effects of IL-4 are impaired in microglia of aged mice. Brain Behav Immun 2012; 26(5): 766-77.
[http://dx.doi.org/10.1016/j.bbi.2011.10.003] [PMID: 22024136]
[54]
Littlefield AM, Setti SE, Priester C, Kohman RA. Voluntary exercise attenuates LPS-induced reductions in neurogenesis and increases microglia expression of a proneurogenic phenotype in aged mice. J Neuroinflammation 2015; 12: 138.
[http://dx.doi.org/10.1186/s12974-015-0362-0] [PMID: 26224094]
[55]
Niraula A, Sheridan JF, Godbout JP. Microglia priming with aging and stress. Neuropsychopharmacol 2017; 42(1): 318-33.
[http://dx.doi.org/10.1038/npp.2016.185]
[56]
Cassano P, Soares CN, Cohen LS, Lyster AK, Fava M. Sex- and age-related differences in major depressive disorder with comorbid anxiety treated with fluoxetine. Arch Women Ment Health 2004; 7(3): 167-71.
[http://dx.doi.org/10.1007/s00737-004-0051-y.] [PMID: 15241662]


open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 3
Year: 2020
Page: [233 - 241]
Pages: 9
DOI: 10.2174/1872211314999201117130123

Article Metrics

PDF: 540
HTML: 2